Abilify MDL Plaintiffs Seek To Sanction Otsuka For Spoliation Of Evidence

(February 12, 2018, 7:16 AM EST) -- PENSACOLA, Fla. — Plaintiffs in the Abilify multidistrict litigation on Feb. 8 asked the court to sanction defendant Otsuka America Pharmaceutical Inc. for alleged spoliation of evidence (In Re:  Ability [Aripiprazole] Products Liability Litigation, MDL Docket No. 2734, N.D. Fla., Pensacola Div.)....

Attached Documents

Related Sections